Zobrazeno 1 - 4
of 4
pro vyhledávání: '"John H. Costanzi"'
Autor:
Wolfram E. Samlowski, Sarah A. Taylor, Thomas Fleming, John H. Costanzi, Daniel D. Von Hoff, Ronald M. Bukowski, Robert B. Natale, Joseph D. McCracken, Jerry T. Guy, Robert W. Talley
Publikováno v:
Investigational new drugs. 8(1)
Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb7d77c484c7c2a3bf2f06a1bc63ab4
https://pubmed.ncbi.nlm.nih.gov/2188928
https://pubmed.ncbi.nlm.nih.gov/2188928
Autor:
A. Kennedy, B. Hoogstraten, Clarence B. Vaughn, Tranum Bl, Henry E. Wilson, W. G. Tucker, Frank E. Smith, John H. Costanzi, Tate Thigpen, T. R. Maloney, Bohumil A. Samal, Robert L. Palmer, Saul E. Rivkin
Publikováno v:
Cancer. 41:2078-2083
Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1, plus 5-FU day 1 and 8, and cyclophosphamide day 1 (AFC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ac3cb4aa9ff298853f742e04b1a6098
https://doi.org/10.1002/1097-0142(197806)41:6<2078::aid-cncr2820410602>3.0.co
https://doi.org/10.1002/1097-0142(197806)41:6<2078::aid-cncr2820410602>3.0.co
Autor:
John N. Bickers, Robert L. Palmer, John H. Costanzi, B. Hoogstraten, Henry E. Wilson, N. Gad El Mawli, Clarence B. Vaughn, L. Heilburn, Tranum Bl, T. R. Maloney, Tate Thigpen, B. McDonald, S. Rasmusen
Publikováno v:
Cancer. 49:835-839
The Southwest Oncology Group tested three combinations of drugs with Adriamycin to identify a best regimen for treatment of advanced breast cancer. Adriamycin, cyclophosphamide, and 5-fluorouracil (5FU)(FAC); Adriamycin and cyclosphosphamide (AC); an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc249e54f51fdf1452844e424ce2d0d2
https://doi.org/10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co
https://doi.org/10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co
Autor:
Barbara A. Neilan, Ronald L. Stephens, John H. Costanzi, Katherine G. Johnson, Robert F. Peterson, Saul E. Rivkin, Ronald M. Bukowski
Publikováno v:
Cancer. 60:2891-2895
A prospective Phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors was conducted by the Southwest Oncology Group. The therapy included 5-fluorouracil, Adriamycin, cyclophosphamide, and streptozotocin (FAC-S) or the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d41abe3d6d9b1948735d0db2584f8a8b
https://doi.org/10.1002/1097-0142(19871215)60:12<2891::aid-cncr2820601207>3.0.co
https://doi.org/10.1002/1097-0142(19871215)60:12<2891::aid-cncr2820601207>3.0.co